Lancet Neurology

Journal

Publication Venue For

  • Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.  19:71-80. 2020
  • Early carotid surgery versus stenting in younger patients – Authors' reply.  18:718-719. 2019
  • Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial.  18:549-558. 2019
  • Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016.  18:459-480. 2019
  • Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016.  18:376-393. 2019
  • Long-term outcomes of stenting and endarterectomy for symptomatic carotid stenosis: a preplanned pooled analysis of individual patient data.  18:348-356. 2019
  • Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.  18:259-268. 2019
  • Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016.  18:56-87. 2019
  • Sex differences in the evaluation and treatment of acute ischaemic stroke.  17:641-650. 2018
  • Intravenous versus subcutaneous immunoglobulin – Authors' reply.  17:393-394. 2018
  • Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data.  17:47-53. 2018
  • Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial.  17:35-46. 2018
  • Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.  16:976-986. 2017
  • Exercise in patients with multiple sclerosis.  16:848-856. 2017
  • Impaired consciousness in patients with absence seizures investigated by functional MRI, EEG, and behavioural measures: a cross-sectional study.  15:1336-1345. 2016
  • DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study.  15:1248-1256. 2016
  • Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis.  15:925-933. 2016
  • Generic-to-generic lamotrigine switches in people with epilepsy: The randomised controlled EQUIGEN trial.  15:365-372. 2016
  • Multiple sclerosis drugs: How much bang for the buck?.  14:460-461. 2015
  • Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: A randomised, controlled, double-blind, double-dummy study.  13:141-149. 2014
  • Davunetide in patients with progressive supranuclear palsy: A randomised, double-blind, placebo-controlled phase 2/3 trial.  13:676-685. 2014
  • MRI lesions: A surrogate for relapses in multiple sclerosis?.  12:628-630. 2013
  • Restenosis after carotid artery stenting and endarterectomy: A secondary analysis of CREST, a randomised controlled trial.  11:755-763. 2012
  • Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): A randomised open-label substudy.  10:969-977. 2011
  • Influence of sex on outcomes of stenting versus endarterectomy: A subgroup analysis of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST).  10:530-537. 2011
  • Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: A double-blind, randomised, controlled trial.  10:509-519. 2011
  • Gene delivery of AAV2-neurturin for Parkinson's disease: A double-blind, randomised, controlled trial.  9:1164-1172. 2010
  • Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes.  7:915-926. 2008
  • Retention of upper limb function in stroke survivors who have received constraint-induced movement therapy: the EXCITE randomised trial.  7:33-40. 2008
  • Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study.  6:773-781. 2007
  • Infectious causes of multiple sclerosis.  5:887-894. 2006
  • Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study.  5:917-923. 2006
  • Alexander disease: GFAP mutations unify young and old.  2:75. 2003
  • St John's wort for the treatment of depression.  1:275. 2002
  • International Standard Serial Number (issn)

  • 1474-4422
  • Electronic International Standard Serial Number (eissn)

  • 1474-4465